切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2020, Vol. 14 ›› Issue (04) : 366 -369. doi: 10.3877/cma.j.issn.1674-3946.2020.04.014

所属专题: 文献

论著

三种手术方式用于结直肠癌肝转移病灶切除的疗效及安全性比较
赵豹1,(), 董磊1, 孙礼山1, 夏猛1   
  1. 1. 234000 皖北煤电集团总医院胃肠外科
  • 收稿日期:2020-04-23 出版日期:2020-08-26
  • 通信作者: 赵豹

Comparison of efficacy and safety of three surgical methods for resection of liver metastases of colorectal cancer

Bao Zhao1,(), Lei Dong1, Lishan Sun1, Meng Xia1   

  1. 1. Department of Gastrointestinal Surgery, General Hospital of North Anhui Coal Power Group, Anhui 234000, China
  • Received:2020-04-23 Published:2020-08-26
  • Corresponding author: Bao Zhao
  • About author:
    Corresponding author: Zhao Bao, Email:
  • Supported by:
    Anhui provincial Project of Health and Family Planning Commission(2016QK050)
引用本文:

赵豹, 董磊, 孙礼山, 夏猛. 三种手术方式用于结直肠癌肝转移病灶切除的疗效及安全性比较[J/OL]. 中华普外科手术学杂志(电子版), 2020, 14(04): 366-369.

Bao Zhao, Lei Dong, Lishan Sun, Meng Xia. Comparison of efficacy and safety of three surgical methods for resection of liver metastases of colorectal cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2020, 14(04): 366-369.

目的

比较三种手术方式用于结直肠癌肝转移病灶切除的疗效及安全性。

方法

回顾性分析2014年1月至2017年1月接受手术治疗的108例结直肠癌肝转移患者病例资料,根据术式不同分为三组,将接受3D腹腔镜辅助肝转移病灶切除术的35例患者纳入3D组,将受2D腹腔镜辅助肝转移病灶切除术的33例患者纳入2D组,将接受传统开腹肝转移病灶切除术的40例患者纳入开腹组。采用SPSS 23.0统计分析软件,符合正态分布的手术相关指标以(±s)表示,多组间均值比较采用单因素方差分析,多组间两两比较采用LSD检验;并发症、生存率以率表示,采用χ2检验,P<0.05为差异有统计学意义。

结果

手术时间、术中出血量、肛门排气时间、住院时间比较,开腹组>2D组>3D组,差异均有统计学意义(P<0.05);三组术后1年、2年、3年生存率比较,差异均无统计学意义(P>0.05)。3D组并发症总发生率(11.4%)与2D组(9.1%)比较,差异无统计学意义(P>0.05);开腹组并发症发生率(30.0%)比3D组、2D组高,差异均有统计学意义(P<0.05)。

结论

3D腹腔镜用于结直肠癌肝转移病灶切除可减少手术时间,降低术后并发症风险,且术后恢复较快,但在提高中远期生存率方面无明显优势。

Objective

To investigate the efficacy and safety of three surgical methods for resection of liver metastases of colorectal cancer.

Method

From January 2014 to January 2017, clinical data of 108 patients with liver metastases from colorectal cancer who underwent surgery were analyzed retrospectively. According to different surgical methods, patients were divided into 3D group (n=35) who underwent 3D laparoscopic-assisted hepatic metastasis resection, 2D group (n=33) who underwent 2D laparoscopic-assisted hepatic metastasis resection, and laparotomy group (n=40) who underwent traditional open hepatic metastasis resection. Statistical analysis were performed by using SPSS 23.0 software. Surgical indicators were expressed as (±s). The mean comparison between multiple groups was analyzed by single factor analysis of variance, and the pairwise comparison between multiple groups was tested by using LSD. Total incidence of complications and survival were expressed as rate and were examined by using χ2 test, A P value <0.05 was considered as statistically significant difference.

Result

In terms of operation time, intraoperative blood loss, anal exhaust time, and hospitalization time, comparison between three groups were as following: laparotomy group> 2D group> 3D group, with significant difference (P<0.05). There was no significant difference in the survival rate between the three groups 1 year, 2 years, and 3 years after surgery (P>0.05). The total incidence of complications in the 3D group (11.4%) was not significantly different from 9.1% in the 2D group (P>0.05); the incidence of complications in the laparotomy group (30.0%) was higher than those in the 3D group and 2D group respectively (P<0.05).

Conclusion

The use of 3D laparoscopy for resection of liver metastases of colorectal cancer could reduce the operation time, the complications with a faster postoperative recovery. However, it has no obvious advantage in improving the long-term survival.

表1 108例结直肠癌肝转移患者不同手术方式三组基础性资料比较[(±s),例]
表2 108例结直肠癌肝转移患者不同手术方式三组手术相关指标比较(±s)
表3 108例结直肠癌肝转移患者不同术式三组患者术后生存率比较[例(%)]
表4 108例结直肠癌肝转移患者不同手术方式三组并发症情况比较[例(%)]
[1]
王志峰,侯小强,李晓江,等.结直肠癌伴肝转移行腹腔镜手术治疗的安全性与有效性[J].实用癌症杂志,2019, 34(2): 278-280.
[2]
马克,王祥宇,陈进宏.同时性结直肠癌肝转移腹腔镜同期切除术与开腹手术的比较研究[J].中华外科杂志,2018, 56(7): 516-521.
[3]
彭宗清,雷斌,黄金锁.腹腔镜下结直肠癌肝转移同时根治切除的临床研究[J/CD].中华普外科手术学杂志(电子版), 2018,12(4): 336-338.
[4]
Watanabe A, Araki K, Harimoto N,et al.D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer[J]. Int J Clin Oncol, 2018,23(4): 689-697.
[5]
中华人民共和国卫生和计划生育委员会医政医管局,中华医学会肿瘤学分会.结直肠癌诊疗规范(2015年版)[J].中国实用外科杂志,2015,53(12): 881-894.
[6]
郭鹏,张治清,兰远志,等.腹腔镜结直肠癌根治术联合肝转移灶射频消融术与开腹结直肠癌肝转移根治术的疗效分析[J].中华消化外科杂志,2018,17(5): 459-465.
[7]
向立历.结直肠癌肝转移诊疗的研究进展[J].中国医药,2019, 14(1): 147-150.
[8]
张桂祥,周家军,陈建曙. 3D腹腔镜下结直肠癌根治术对患者免疫功能及生理功能的影响[J].广西医科大学学报,2018, 35(10): 1358-1362.
[9]
李广涛,朱晓琳,何红莹,等.射频消融与手术切除治疗结直肠癌肝转移的疗效比较[J].中华肝胆外科杂志,2019,25(7): 487-492.
[10]
Parchur AK, Sharma G, Jagtap JM,et al.Vascular Interventional Radiology Guided Photothermal Therapy of Colorectal Cancer Liver Metastasis with Theranostic Gold Nanorods[J]. ACS Nano, 2018,12(7): 6597-6611.
[11]
Chu PC, Lin PC, Wu HY,et al.Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway[J].Oncogene, 2018, 37(25): 3440-3455.
[12]
毛瑞波,方冠,李绍,等.结直肠癌伴同时性肝转移同期腹腔镜手术与开腹手术的比较[J].肝胆胰外科杂志,2019, 31(4): 212-216.
[13]
蒋斌,修典荣.腹腔镜肝脏切除术在结直肠癌肝转移中的应用进展[J].国际外科学杂志,2019, 46(2): 76-81.
[14]
陶振洲,曹广,梁杰雄,等.3D与2D腹腔镜结直肠癌根治术临床疗效比较[J].中国医药,2018,13(6): 895-898.
[15]
Yimin S, Caihua W, Yuezhong R,et al.A comprehensive look at the role of hyperlipidemia in promoting colorectal cancer liver metastasis[J]. Journal of Cancer, 2018, 9(16): 2981-2986.
[16]
Chapelle N, Matysiak-Budnik T, Douane F,et al.Hepatic arterial infusion in the management of colorectal cancer liver metastasis: Current and future perspectives[J]. Dig Liver Dis, 2018, 50(3): 220-225.
[17]
洪希周,马君俊,董峰,等.3D与2D腹腔镜系统在结直肠癌手术应用的随机对照研究[J].腹部外科,2017, 30(1): 23-26,35.
[18]
陈俊生,张红亮,那兴邦,等.3D腹腔镜与传统开腹手术切除结直肠癌肝转移病灶的安全性比较[J].解放军医学院学报,2018,39(7): 564-566,588.
[1] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[3] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[4] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[5] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[6] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[7] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[8] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[9] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[10] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[11] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[12] 李博, 贾蓬勃, 李栋, 李小庆. ERCP与LCBDE治疗胆总管结石继发急性重症胆管炎的效果[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 60-63.
[13] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[14] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[15] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
阅读次数
全文


摘要